Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript May 12, 2025
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.
Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kathryn Flynn, the Corporate...
